Skip to main content

Table 4 Metformin concentrations in organs/tissues of different organisms after treatment

From: Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy

Organism

Dose

Time (h)

Intestine (μmol/kg wet weight)

Plasma (μmol/l)

Liver (μmol/kg wet weight)

Muscle (μmol/kg wet weight)

Adipose tissue (μmol/kg wet weight)

Stomach (μmol/kg wet weight)

Kidney (μmol/kg wet weight)

Refs

Human

2*850 mg; 6–8 weeks

3

4000

8–24

     

[30]

Human

2*850 mg; 6–8 weeks

12–16

250

< 8

     

[30]

Mice

1.25–1.5 mg (50 mg/kg)

0.5, 1, 2, 4, 8

3729; 5554; 3212; 2061; 803;

IVC: 28.9; 28.1; 12.6; 14.7; 6.6

HPV: 51.7; 39; 19; 18.5; 9.3;

182, 154, 115, 37, 32

22, 28, 87, 58, 15

12, 14, 16, 11, 2

800, 965, 331, 129, 124

428, 246, 172, 121, 71

[184]

STZ diabetic mice

1.25–1.5 mg (50 mg/kg)

0.5, 1, 2, 4, 8

2161; 2585; 5546; 1261; 500

IVC: 35.4; 34.3; 21.5; 11.2

HPV: 61.5; 54.9; 28; 14.4; 8.9;

282, 137, 86, 53,32

66, 24, 16, 14, 16

42, 26, 75, 30, 20

541, 367, 783, 64, 52

384, 428, 229, 107, 63

[184]

Rat

~6 mg (50 mg/kg)

0.5

 

IVC: 14

49.6 ± 13.5

    

[15]

Rat

~6 mg (50 mg/kg)

4

 

IVC: 6.5

28.3 ± 7.3

    

[15]

  1. IVC inferior vena cava, HPV hepatic portal vein, STZ streptozotocin